Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women

Circulation

Volumn 125, Issue 12, 2012, Pages 1482-1490

  Melzer, David ^a   Osborne, Nicholas J ^f   Henley, William E ^b   Cipelli, Riccardo ^a   Young, Anita ^c   Money, Cathryn ^c   McCormack, Paul ^c   Luben, Robert ^e   Khaw, Kay Tee ^e   Wareham, Nicholas J ^a,d   Galloway, Tamara S ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b UNIVERSITY OF PLYMOUTH   (United Kingdom)

^c Brixham Environmental Laboratory   (United Kingdom)

^d MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f NONE

Author keywords

bisphenol A; blood lipids; body mass index; coronary artery disease; endocrine disruption

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ASCORBIC ACID; C REACTIVE PROTEIN; CREATININE; LIPID;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; CREATININE URINE LEVEL; EDUCATIONAL STATUS; EXERCISE; FEMALE; FOLLOW UP; HUMAN; KIDNEY CONCENTRATING CAPACITY; MAJOR CLINICAL STUDY; MALE; OCCUPATION; PRIORITY JOURNAL; RISK ASSESSMENT; SOCIAL CLASS; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; URINALYSIS; URINE LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PHENOLS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84859107392     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.069153     Document Type: Article

References (51)

1. Ritter S. Debating BPA's toxicity. Chem Eng News. 2011;89:5-13.
2. Dodds E, Lawson W. Synthetic estrogenic agents without the phenanthrene nucleus. Nature. 1936;137:996.
3. Diamanti-Kandarakis E, Palioura E, Kandarakis SA, Koutsilieris M. The impact of endocrine disruptors on endocrine targets. Horm Metab Res. 2010;42:543-552.
4. Lakind JS, Naiman DQ. Daily intake of bisphenol A and potential sources of exposure: 2005-2006 National Health and Nutrition Examination Survey. J Expo Sci Environ Epidemiol. 2008;21:272-279.
5. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect. 2005;113:391-395.
6. Ye XB, Pierik FH, Hauser R, Duty S, Angerer J, Park MM, Burdorf A, Hofman A, Jaddoe VWV, Mackenbach JP, Steegers EAP, Tiemeier H, Longnecker MP. Urinary metabolite concentrations of organophosphorous pesticides, bisphenol A, and phthalates among pregnant women in Rotterdam, the Netherlands: the Generation R study. Environ Res. 2008;108:260-267.
7. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB, Melzer D. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA. 2008; 300:1303.
8. vom Saal FS, Myers JP. Bisphenol A and risk of metabolic disorders. JAMA. 2008;300:1353-1355.
9. Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS One. 2010;5:e8673.
10. European Food Standards Agency. European Food Standards Agency scientific opinion on bisphenol A: evaluation of a study investigating its neurodevelopmental toxicity and review of recent scientific literature on its toxicity. EFSA J. 2010;8:1829-1945.
11. Hengstler JG, Foth H, Gebel T, Kramer PJ, Lilienblum W, Schweinfurth H, Volkel W, Wollin KM, Gundert-Remy U. Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A. Crit Rev Toxicol. 2011;41:263-291.
12. Boekholdt SM, Kuivenhoven JA, Wareham NJ, Peters RJ, Jukema JW, Luben R, Bingham SA, Day NE, Kastelein JJ, Khaw KT. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation Into Cancer and Nutrition)-Norfolk population study. Circulation. 2004;110:1418-1423.
13. Day N, Oakes S, Luben R, Khaw KT, Bingham S, Welch A, Wareham N. EPIC-Norfolk: study design and characteristics of the cohort. Br J Cancer. 1999;80:95-103.
14. Canoy D, Boekholdt SM, Wareham N, Luben R, Welch A, Bingham S, Buchan I, Day N, Khaw KT. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation. 2007;116:2933-2943.
15. Boekholdt SM, Peters RJG, Day NE, Luben R, Bingham SA, Wareham NJ, Hack CE, Reitsma PH, Khaw K-T. Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk prospective population study. Am J Med. 2004;117: 390-397.
16. WHO. Background paper on bisphenol A biomonitoring and biomarker techniques. World Health Organisation Food and Agriculture Organisation of the United Nations Web site. Published 2010. WHO/HSE/FOS/11.1.
17. Calafat AM, Ye XY, Wong LY, Reidy JA, Needham LL. Exposure of the US population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect. 2008;116:39-44.
18. Galloway T, Cipelli R, Guralnick J, Ferrucci L, Bandinelli S, Corsi AM, Money C, McCormack P, Melzer D. Daily bisphenol A excretion and associations with sex hormone concentrations: results from the InCHIANTI adult population study. Environ Health Perspect. 2010;118: 1603-1608.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
20. Bruins P, Te Velthuis H, Yazdanbakhsh AP, Jansen PGM, Van Hardevelt FWJ, De Beaumont EMFH, Wildevuur CRH, Eijsman L, Trouwborst A, Hack CE. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997;96:3542-3548.
21. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the US population: implications for urinary biologic monitoring measurements. Environ Health Perspect. 2005;113:192-200.
22. Wood SN. On confidence intervals for generalized additive models based on penalized regression splines. Aust NZ J Stat. 2006;48:445-464.
23. Melzer D, Galloway TS. Bisphenol A and adult disease: making sense of fragmentary data and competing inferences. Ann Intern Med. 2011;155: 392-394.
24. Mahalingaiah S, Meeker JD, Pearson KR, Calafat AM, Ye X, Petrozza J, Hauser R. Temporal variability and predictors of urinary bisphenol A concentrations in men and women. Environ Health Perspect. 2008; 116:173.
25. Nepomnaschy PA, Baird DD, Weinberg CR, Hoppin JA, Longnecker MP, Wilcox AJ. Within-person variability in urinary bisphenol A concentrations: measurements from specimens after long-term frozen storage. Environ Res. 2009;10:734-737.
26. Ye X, Wong LY, Bishop AM, Calafat AM. Variability of urinary concentrations of bisphenol A in spot samples, first-morning voids, and 24-hour collections. Environ Health Perspect. 2011;119:983-988.
27. Völkel W, Colnot T, Csanády GA, Filser JG, Dekant W. Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem Res Tox. 2002;15:1281-1287.
28. Sieli P, Jas̈arevic E, Warzak D, Mao J, Ellersieck M, Liao C, Kannan K, Collet S, Toutain P, vom Saal F, Rosenfeld C. Comparison of serum bisphenol A concentrations in mice exposed to bisphenol A through the diet versus oral bolus exposure. Environ Health Perspect. 2011;119: 1260-1265.
29. Stahlhut RW, Welshons WV, Swan SH. Bisphenol A data in NHANES suggest longer than expected half life, substantial nonfood exposure, or both. Environ Health Perspect. 2009;117:784-789.
30. Dekant W, Volkel W. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol. 2008;228:114-134.
31. Biedermann S, Tschudin P, Grob K. Transfer of bisphenol A from thermal printer paper to the skin. Anal Bioanal Chem. 2010;398:571-576.
32. Teeguarden JG, Waechter JM Jr, Clewell HJ III, Covington TR, Barton HA. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach. Toxicol Sci. 2005;85: 823-838.
33. Taylor JA, Vom Saal FS, Welshons WV, Drury B, Rottinghaus G, Hunt PA, Toutain PL, Laffont CM, VandeVoort CA. Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ Health Perspect. 2010;119:422-430.
34. Sharpe RM. Bisphenol A exposure and sexual dysfunction in men: editorial commentary on the article 'Occupational exposure to bisphenol-A (BPA) and the risk of self-reported male sexual dysfunction.' Hum Reprod. 2010;25:292-294.
35. Michels KB, Welch AA, Luben R, Bingham SA, Day NE. Measurement of fruit and vegetable consumption with diet questionnaires and implications for analyses and interpretation. Am J Epidemiol. 2005;161: 987-994.
36. Bonefeld-Jorgensen EC, Long M, Hofmeister MV, Vinggaard AM. Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review. Environ Health Perspect. 2007;115:69-76.
37. Mastin JP. Environmental cardiovascular disease. Cardiovasc Toxicol. 2005;5:91-94.
38. Okada H, Tokunaga T, Liu XH, Takayanagi S, Matsushima A, Shimohigashi Y. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptorgamma. Environ Health Perspect. 2008;116:32-38.
39. Melzer DH, Harries L, Cipelli R, Henley W, Money C, McCormack P, Young A, Guralnik J, Ferrucci L, Bandinelli S, Corsi AM, Galloway T. Bisphenol A exposure is associated with in-vivo estrogenic gene expression in adults. Environ Health Perspect. 2011;119:1788-1793.
40. Lee HJ, Chattopadhyay S, Gong EY, Ahn RS, Lee K. Antiandrogenic effects of bisphenol A and nonylphenol on the function of the androgen receptor. Toxicol Sci. 2003;75:40-46.
41. Guillemette C, Levesque E, Beaulieu M, Turgeon D, Hum DW, Belanger A. Differential regulation of two uridine diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells. Endocrinology. 1997;138:2998-3005.
42. Kandaraki E, Chatzigeorgiou A, Livadas S, Palioura E, Economou F, Koutsilieris M, Palimeri S, Panidis D, Diamanti-Kandarakis E. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J Clin Endocrinol Metab. 2011; 96:E480.
43. Basaria S, Coviello A, Travison T, Storer T, Farwell W, Jette A, Eder R, Tennstedt, Ph.D., Jagadish Ulloor S, Zhang A, Choong K, Lakshman K, Mazer N, Miciek R, Krasnoff J, Elmi A, Knapp P, Brooks B, Appleman E, Aggarwal S, Bhasin G, Hede-Brierley L, Bhatia A, Collins L, LeBrasseur N, Fiore L, Bhasin S. Adverse events associated with testosterone administration. N Engl J Med. 2010;363:109-122.
44. Okuda K, Takiguchi M, Yoshihara S. In vivo estrogenic potential of 4-methyl-2, 4-bis (4-hydroxyphenyl) pent-1-ene, an active metabolite of bisphenol A, in uterus of ovariectomized rat. Toxicol Letts. 2010; 197:7-11.
45. Brenner R, Perez GJ, Bonev AD, Eckman DM, Kosek JC, Wiler SW, Patterson AJ, Nelson MT, Aldrich RW. Vasoregulation by the beta1 subunit of the calcium-activated potassium channel. Nature. 2000;407: 870-876.
46. Asano S, Tune JD, Dick GM. Bisphenol A activates Maxi-K (K(Ca)1.1) channels in coronary smooth muscle. Br J Pharmacol. 2010;160: 160-170.
47. Bindhumol V, Chitra KC, Mathur PP. Bisphenol A induces reactive oxygen species generation in the liver of male rats. Toxicology. 2003; 188:117.
48. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect. 2006; 114:106.
49. Ropero AB, Alonso-Magdalena P, Garcia-Garcia E, Ripoll C, Fuentes E, Nadal A. Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl. 2008;31:194-200.
50. Eto K, Ohya Y, Nakamura Y, Abe I, Fujishima M. Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle. Eur J Pharmacol. 2001;423:1-7.
51. Wright HM, Clish CB, Mikami T, Hauser S, Yanagi K, Hiramatsu R, Serhan CN, Spiegelman BM. A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation. J Biol Chem. 2000;275:1873-1877.